在心肌梗塞后,酸通过释放巨细胞蛋白酸酶5促进炎症
Zhipeng Chen1,2, Jiawei Song1,2, Suli Feng1,2
1State Key Laboratory of Experimental Hematology, Tianjin Institute of Cardiology, Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Second Hospital of Tianjin Medical University, Tianjin Medical University, 22 Qixiangtai Road, Tianjin 300070, China.
European heart journal
|September 4, 2025
概括
心肌梗塞 (MI) 后的炎症阻碍了心脏的修复. 这项研究揭示了阿拉基酸 (AA) 代谢,特别是白血B4 (LTB4) 生产如何驱动这种炎症,确定了蛋白酸酶5 (PP5) 作为治疗点.
科学领域:
- 心血管生物学
- 免疫学
- 代谢学
背景情况:
- 心肌梗塞 (MI) 引发炎症反应,影响心脏组织的修复.
- 免疫细胞透,特别是巨细胞,在心脏病发作后的心脏重塑和功能障碍中起着至关重要的作用.
- 了解炎症的分子媒介对于开发有效的MI治疗至关重要.
研究的目的:
- 为了研究甲基酸 (AA) 代谢级联在心脏病发作后的炎症中的作用.
- 确定导致心脏炎症和心脏中风后修复障碍的关键分子机制.
- 探索潜在的治疗目标,以减轻心脏中风后的不良心脏重塑.
主要方法:
- 单细胞RNA测序以分析小鼠MI模型中的心脏巨异质性.
- 来自心脏病发作患者的血和心脏病发作小鼠的心脏组织的代谢分析.
- 研究甲基酸 (AA),蛋白酸酶5 (PP5) 和5-脂氧酶 (5-LOX) 在调节白血素B4 (LTB4) 产生的相互作用.
主要成果:
- 在MI患者和小鼠模型中,AA代谢物Leukotriene B4 (LTB4) 显著升高,与复发性MI相关.
- 阿拉基酸 (AA) 促进了蛋白质酸酶5 (PP5) 的核转移,从而导致5-脂氧酶 (5-LOX) 的脱化和持续的LTB4产生.
- 这种机制增强了CXCL13介导的B细胞招募,并通过巨细胞与B细胞的交叉通话扩大了炎症;破坏巨细胞中的PP5改善了这些效应.
结论:
- 这项研究阐明了一种涉及5-氧酶 (5-LOX) 酸化调节的LTB4水平在心肌梗塞 (MI) 中的保存机制.
- 蛋白酸酶5 (PP5) 通过维持LTB4的产生,在中介性后心脏病炎症中发挥关键作用.
- 蛋白酸酶5 (PP5) 成为治疗心肌梗塞的潜在治疗点.
相关概念视频
01:38Inflammation
55.0K
Overview
55.0K
01:26Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45
01:11IP3/DAG Signaling Pathway
12.4K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.4K
01:21Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
01:30Peripheral Artery Disease I: Introduction
32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32